These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9043771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL.
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fludarabine phosphate--looking forward.
    Cheson BD.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract] [Full Text] [Related]

  • 8. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
    Rodriguez G.
    Invest New Drugs; 1994 Oct; 12(2):75-92. PubMed ID: 7532163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
    Dimopoulos MA, Weber DM, Kantarjian H, Keating M, Alexanian R.
    Ann Oncol; 1994 Mar; 5(3):288-9. PubMed ID: 7514439
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
    Keating MJ, McLaughlin P, Plunkett W, Robertson LE, O'Brien S, Gandhi V, Gregoire V, Yang L, Cabanillas F.
    Ann Oncol; 1994 Mar; 5 Suppl 2():79-83. PubMed ID: 8204523
    [Abstract] [Full Text] [Related]

  • 16. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP.
    Nouv Rev Fr Hematol (1978); 1988 Apr; 30(5-6):457-9. PubMed ID: 2464793
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Why do drugs work in CLL?
    Plunkett W, Begleiter A, Liliemark JO, Reed JC.
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():1-11. PubMed ID: 9021705
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.